Platform Technology for Developing Purification Processes - A structural approach to resin screening and process optimization can accelerate the development of purification platforms. - BioPharm

ADVERTISEMENT

Platform Technology for Developing Purification Processes
A structural approach to resin screening and process optimization can accelerate the development of purification platforms.


BioPharm International Supplements


References

1. Frost & Sullivan. Strategic analysis of world downstream processing markets in biopharmaceutical production. 2004.

2. Wang T, John S, Archuleta S, Jonsson CB. Rapid, high-throughput purification of HIV-1 integrase using microtiter plate technology, Protein Expres Purif. 2004;33:232–37.

3. Eeckhout D, De Clercq A, Van de Slijke E, Van Leene J, Sals H, Casteels P, et al. A technology platform for the fast production of monoclonal recombinant antibodies against plant proteins and peptides. J Immunol Methods. 2004;294:181–7.

4. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 2000;21: 1164–77.

5. Weinberger SR, Viner RI, Ho P. Tagless extractionretentate chromatography: A new global protein digestion strategy for monitoring differential protein expression. Electrophoresis. 2002;23:3182–92.

6. Seibert V, Ebert MPA, Buschmann T. Advances in clinical cancer proteomics: SELDI–T–of-mass spectrometry and biomarker discovery. Br Funct Genomic Proteomic. 2005;4:16–26.

7. Seibert V, Wiesner A, Buschmann T, Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF–MS) and ProteinChip technology in proteomics research. Pathol Res Pract. 2004;200:83–94.

8. Montgomery DC. Design and Analysis of Experiments. New York, NY: Wiley & Sons, Inc;2001.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
April 10, 2014
Merck Announes Management Changes
April 7, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here